Literature DB >> 24048876

Seizures and epilepsy in children.

Anita Sharma1.   

Abstract

Seizures and epilepsy in children are common. They are caused by a variety of causes ranging from genetic to neuro -infections. History and actual observation or/video are very important to differentiate true seizure from non-epileptic event. A correct classification of seizure and epilepsy helps to decide need to treat, choice of anti-epileptic drugs (AED) and prognostication. Except for few seizure types, in majority of seizure types regular AED are started after second confirmed seizure. Goal of treatment is seizure control with minimal side effects and ensuring quality of life. With appropriate mono - therapy, about 70 % patients become seizure free and can be easily treated in community. An orderly approach to classify seizure type, holistic management and timely referral of intractable epilepsy will help in improving care of children with epilepsy.

Entities:  

Mesh:

Year:  2013        PMID: 24048876     DOI: 10.1007/s12098-013-1173-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  30 in total

Review 1.  Initiation and discontinuation of antiepileptic drugs.

Authors:  C O'Dell; S Shinnar
Journal:  Neurol Clin       Date:  2001-05       Impact factor: 3.806

Review 2.  Medical therapy of epilepsy: when to initiate treatment and when to combine?

Authors:  Martin J Brodie
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

3.  ILAE Commission report. Restrictions for children with epilepsy. Commission of Pediatrics of the ILAE. International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1997-09       Impact factor: 5.864

4.  Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. American Academy of Pediatrics. Provisional Committee on Quality Improvement, Subcommittee on Febrile Seizures.

Authors: 
Journal:  Pediatrics       Date:  1996-05       Impact factor: 7.124

5.  Risk of recurrent seizures after two unprovoked seizures.

Authors:  W A Hauser; S S Rich; J R Lee; J F Annegers; V E Anderson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

6.  Epilepsy syndromes in patients with childhood-onset seizures in Finland.

Authors:  M Sillanpää; M Jalava; S Shinnar
Journal:  Pediatr Neurol       Date:  1999-08       Impact factor: 3.372

Review 7.  Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.

Authors:  Jacqueline A French; Andres M Kanner; Jocelyn Bautista; Bassel Abou-Khalil; Thomas Browne; Cynthia L Harden; William H Theodore; Carl Bazil; John Stern; Steven C Schachter; Donna Bergen; Deborah Hirtz; Georgia D Montouris; Mark Nespeca; Barry Gidal; William J Marks; William R Turk; James H Fischer; Blaise Bourgeois; Andrew Wilner; R Edward Faught; Rajesh C Sachdeo; Ahmad Beydoun; Tracy A Glauser
Journal:  Epilepsia       Date:  2004-05       Impact factor: 5.864

8.  Diagnosis and management of the epilepsies in children: a summary of the partial update of the 2012 NICE epilepsy guideline.

Authors:  Richard E Appleton; Amanda Freeman; J Helen Cross
Journal:  Arch Dis Child       Date:  2012-10-06       Impact factor: 3.791

Review 9.  Epilepsy in children.

Authors:  Renzo Guerrini
Journal:  Lancet       Date:  2006-02-11       Impact factor: 79.321

Review 10.  Epilepsy: a review of reports, guidelines, recommendations and models for the provision of care for patients with epilepsy.

Authors:  Rebecca L M Aylward
Journal:  Clin Med (Lond)       Date:  2008-08       Impact factor: 2.659

View more
  1 in total

1.  Hospital admissions for seizure in Italy: a decennial retrospective analysis with a special focus on the burden in the pediatric age.

Authors:  Giovanni Gabutti; Parvané Kuhdari; Sara Ferioli; Cecilia Trucchi
Journal:  Neurol Sci       Date:  2015-04-30       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.